These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4075918

  • 1. [Treatment of 37 cases of tardive dyskinesia by deanol].
    Cai N.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Aug; 18(4):234-6. PubMed ID: 4075918
    [No Abstract] [Full Text] [Related]

  • 2. [Dimethylaminoethanol in the treatment of neuroleptic-induced tardive dyskinesia].
    Lambert PA, Wolff P, de Maximy B, Ghenim A.
    Ann Med Psychol (Paris); 1978 Apr; 136(4):625-9. PubMed ID: 31832
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R, Hobi V, Linder M, Studer K.
    Schweiz Arch Neurol Neurochir Psychiatr; 1980 Apr; 126(1):103-9. PubMed ID: 6106283
    [Abstract] [Full Text] [Related]

  • 4. Tardive dyskinesia treated with deanol acetamidobenzoate.
    Ray I.
    Can Med Assoc J; 1977 Jul 23; 117(2):129. PubMed ID: 872010
    [No Abstract] [Full Text] [Related]

  • 5. Deanol in tardive dyskinesia.
    Davis KL, Berger PA, Hollister LE.
    Am J Psychiatry; 1977 Jul 23; 134(7):807. PubMed ID: 869061
    [No Abstract] [Full Text] [Related]

  • 6. Electromyographic assessment of dimethylaminoethanol (deanol) in treatment of tardive dyskinesia.
    Lonowski DJ, Sterling FE, King HA.
    Psychol Rep; 1979 Oct 23; 45(2):415-9. PubMed ID: 538170
    [No Abstract] [Full Text] [Related]

  • 7. Double-blind evaluation of deanol in tardive dyskinesia.
    Penovich P, Morgan JP, Kerzner B, Karch F, Goldblatt D.
    JAMA; 1978 May 12; 239(19):1997-8. PubMed ID: 347112
    [Abstract] [Full Text] [Related]

  • 8. Deanol in the management of involuntary movement disorders: a review.
    Casey DE.
    Dis Nerv Syst; 1977 Dec 12; 38(12 Pt 2):7-15. PubMed ID: 145359
    [No Abstract] [Full Text] [Related]

  • 9. Letter: Deanol for tardive dyskinesia.
    N Engl J Med; 1975 Apr 24; 292(17):926-7. PubMed ID: 1117921
    [No Abstract] [Full Text] [Related]

  • 10. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A, Villeneuve A, Gautier J, Jus K, Villeneuve C, Pires P, Villeneuve R.
    Neuropsychobiology; 1978 Apr 24; 4(3):140-9. PubMed ID: 340975
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia.
    Stafford JR, Fann WE.
    Dis Nerv Syst; 1977 Dec 24; 38(12 Pt 2):3-6. PubMed ID: 590063
    [Abstract] [Full Text] [Related]

  • 19. Deanol acetamidobenzoate treatment in choreiform movement disorders.
    Tarsy D, Bralower M.
    Arch Neurol; 1977 Dec 24; 34(12):756-8. PubMed ID: 145212
    [Abstract] [Full Text] [Related]

  • 20. Letter: Deanol: a solution for tardive dyskinesia?
    Miller EM.
    N Engl J Med; 1974 Oct 10; 291(15):796-7. PubMed ID: 4414178
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.